Previous Close | 19.47 |
Open | 19.60 |
Bid | 18.89 x 1000 |
Ask | 19.55 x 800 |
Day's Range | 19.40 - 19.75 |
52 Week Range | 17.24 - 26.56 |
Volume | |
Avg. Volume | 231,569 |
Market Cap | 898.798M |
Beta (5Y Monthly) | 0.97 |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Avanos Medical, Inc. (NYSE: AVNS) today reported first quarter 2024 financial results.
Avanos Medical, Inc. (NYSE: AVNS) will webcast its conference call discussing financial results and business highlights for the first quarter 2024 on Thursday, May 2 at 9 a.m., ET. The company will issue a news release detailing its results before the market opens that same day.
In direct response to the Nurse Assist, LLC voluntary recall of pre-filled syringes and other sterile water products, Avanos Medical, Inc. (NYSE: AVNS) voluntarily recalled specific lots of MIC* Gastric – Jejunal Feeding Tube Kits on Jan. 16, 2024. These kits include Nurse Assist supplied syringes, pre-filled with sterile water, essential for inflating the retention balloon of the feeding tube.